PE3096A1 - Formulacion conteniendo selenio - Google Patents

Formulacion conteniendo selenio

Info

Publication number
PE3096A1
PE3096A1 PE1995263638A PE26363895A PE3096A1 PE 3096 A1 PE3096 A1 PE 3096A1 PE 1995263638 A PE1995263638 A PE 1995263638A PE 26363895 A PE26363895 A PE 26363895A PE 3096 A1 PE3096 A1 PE 3096A1
Authority
PE
Peru
Prior art keywords
selenium
livestock
antibiotic
formulation containing
containing selenium
Prior art date
Application number
PE1995263638A
Other languages
English (en)
Inventor
Lionel Barry Lowe
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PE3096A1 publication Critical patent/PE3096A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/04Sulfur, selenium or tellurium; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

CARACTERIZADA POR COMPRENDER: 1) DE 0,5% A 60% DE UN IONOFORO QUE PUEDE SER: A) CARBOXILICO; o B) ANTIBIOTICO POLIETER, DE PREFERENCIA MONENSINA, NARASINA, LASALOCIDA O SALINOMICINA; 2) DE 0,01% A 2% DE UN COMPUESTO DE SELENIO, EN FORMA DE SALES DE SELENIO, SELENIUROS, SELENATOS, SELENITOS O SELENIO ELEMENTAL; 3) DE 40% A 99% DE UN VEHICULO, DILUYENTE, EXCIPIENTE Y/O ADYUVANTE ACEPTABLE PARA USO VETERINARIO; ADICIONALMENTE PUEDE CONTENER: UN ANTIBIOTICO GLICOPEPTIDO, UN ANTIHELMINTICO, UN ECTOPARASITICIDA, UN SURFACTANTE NO IONICO O UN AGENTE ANTIESPUMANTE DE SILICONA. DICHA COMPOSICION PUEDE ADMINISTRARSE DIARIAMENTE CON LOS ALIMENTOS O MEDIANTE UNA CAPSULA INTRODUCIDA EN EL RUMEN DEL GANADO, Y PERMITE ELEVAR LA ABSORCION DE SELENIO Y MEJORAR LA GANANCIA DE PESO DEL GANADO
PE1995263638A 1994-03-08 1995-03-08 Formulacion conteniendo selenio PE3096A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPM4308A AUPM430894A0 (en) 1994-03-08 1994-03-08 A formulation and methods of treatment (1)

Publications (1)

Publication Number Publication Date
PE3096A1 true PE3096A1 (es) 1996-03-04

Family

ID=3778924

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1995263638A PE3096A1 (es) 1994-03-08 1995-03-08 Formulacion conteniendo selenio

Country Status (17)

Country Link
EP (1) EP0671174B1 (es)
CN (1) CN1082794C (es)
AT (1) ATE288276T1 (es)
AU (2) AUPM430894A0 (es)
BR (1) BR9501006A (es)
CA (1) CA2144135C (es)
CO (1) CO4410202A1 (es)
DE (1) DE69533974T2 (es)
DK (1) DK0671174T3 (es)
ES (1) ES2236697T3 (es)
FI (1) FI951060A7 (es)
MY (1) MY121561A (es)
NO (1) NO950871L (es)
NZ (1) NZ270639A (es)
PE (1) PE3096A1 (es)
PT (1) PT671174E (es)
RU (1) RU2145845C1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ280384A (en) 1995-11-02 1997-01-29 Lilly Eli & Co Nz Ltd Animal feed supplement comprising a wettable powder composition of an ionophore antibiotic
ES2207683T3 (es) * 1995-11-02 2004-06-01 ELI LILLY & COMPANY( NZ) LIMITED Composiciones secas de antibioticos ionoforos.
US6086633A (en) * 1996-10-17 2000-07-11 Eli Lilly And Company Method for preserving animal hides
CA2269066C (en) * 1996-10-17 2005-04-26 Eli Lilly And Company Method for preserving animal hides
AU784122B2 (en) 1999-12-29 2006-02-09 Boris Khaimovich Strelets Physiologically active agents containing vicinal dithioglycols and use thereof in various branches of economy
RU2158517C1 (ru) * 2000-02-25 2000-11-10 Зенович Сергей Михайлович Физиологически активное средство для животных и птицы, способ его получения, кормовая добавка и способ кормления животных и птицы
ZA200807832B (en) * 2007-04-04 2010-05-26 Alharma Inc Maduramicin compositions and methods
MY162336A (en) * 2008-06-03 2017-06-15 Zoetis Services Llc Lasalocid compositions and methods
AU2012294823A1 (en) * 2011-08-05 2014-01-16 Eli Lilly And Company Animal supplements and compositions containing soluble monensin and methods therefor
GB201305520D0 (en) * 2013-03-26 2013-05-08 Mars Inc Edible Animal Chew
US10548911B2 (en) 2014-06-16 2020-02-04 University Of Rochester Small molecule anti-scarring agents
RU2584226C2 (ru) * 2014-09-22 2016-05-20 Александр Александрович Кролевец Способ получения нанокапсул антибиотиков в интерфероне
RU2580613C1 (ru) * 2014-09-22 2016-04-10 Александр Александрович Кролевец Способ получения нанокапсул антибиотиков в агар-агаре
FI3258920T3 (fi) 2015-02-17 2023-06-28 Univ Gent Juomavesilääkkeenä käytettäväksi soveltuva kiinteä farmaseuttinen annosmuoto
GB201715660D0 (en) 2017-09-27 2017-11-08 Mars Inc Jaw assembly
RU2762327C1 (ru) * 2020-09-30 2021-12-17 Федеральное государственное бюджетное научное учреждение "Краснодарский научный центр по зоотехнии и ветеринарии" ФГБНУ КНЦЗВ Фармакологическое средство, обладающее антиоксидантными и гепатопротекторными свойствами
EP4477215A3 (en) 2020-12-08 2025-02-19 Ruminant Biotech Corp Limited Improvements to devices and methods for delivery of substances to animals

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3839557A (en) * 1972-01-24 1974-10-01 Lilly Co Eli Antibiotics monensin and a204 for improving ruminant feed efficiency
US4618604A (en) * 1983-09-26 1986-10-21 Monsanto Company Composition and method for improving feed utilization or tissue production in animals
US4649042A (en) * 1984-05-31 1987-03-10 Eli Lilly And Company Rumen delivery device
AU650113B2 (en) * 1991-04-05 1994-06-09 Eli Lilly And Company Sustained release capsule and formulations
US5462741A (en) * 1992-08-06 1995-10-31 Alza Corporation High agent loaded controlled release dispenser

Also Published As

Publication number Publication date
CN1082794C (zh) 2002-04-17
EP0671174A2 (en) 1995-09-13
FI951060L (fi) 1995-09-09
ES2236697T3 (es) 2005-07-16
FI951060A0 (fi) 1995-03-07
NO950871L (no) 1995-09-11
BR9501006A (pt) 1995-10-24
CA2144135A1 (en) 1995-09-09
AU690188B2 (en) 1998-04-23
ATE288276T1 (de) 2005-02-15
DK0671174T3 (da) 2005-05-17
AUPM430894A0 (en) 1994-03-31
NO950871D0 (no) 1995-03-07
EP0671174A3 (en) 1999-01-27
PT671174E (pt) 2005-05-31
DE69533974D1 (de) 2005-03-10
RU2145845C1 (ru) 2000-02-27
FI951060A7 (fi) 1995-09-09
NZ270639A (en) 1996-06-25
EP0671174B1 (en) 2005-02-02
CO4410202A1 (es) 1997-01-09
CN1117351A (zh) 1996-02-28
MY121561A (en) 2006-02-28
CA2144135C (en) 1999-09-21
AU1367795A (en) 1995-09-14
DE69533974T2 (de) 2006-01-05
RU95103431A (ru) 1996-12-10

Similar Documents

Publication Publication Date Title
PE3096A1 (es) Formulacion conteniendo selenio
ES2099094T3 (es) Metodos y composiciones para tratamiento de interacciones hidrofobas patologicas en fluidos biologicos.
ES2084174T3 (es) Productos y procesos para el tratamiento del conducto alimentario.
ES2130217T3 (es) Uso de tiloxapol como dispersante y estabilizante de nanoparticulas.
ES2065178T3 (es) Dispositivo osmotico para el suministro retardado de un agente.
ES2117015T3 (es) Composiciones que contienen sumatriptan.
CO5700796A2 (es) Composiciones que contienen piperacilina y tazobactam utiles para inyecciones
AR018109A1 (es) FORMULACIoN GALÉNICA ADMINISTRABLE POR VíA ORAL QUE PERMITE UNA ABSORCIoN MEJORADA DE PRINCIPIOS ACTIVOS, USO DE UN AGENTE MAJORADOR DE ABSORCIoN PARA PREPARAR UNA FORMA DE DOSIFICACIoN ADMINISTRABLE POR VíA ORAL Y PROCEDIMIENTO PARA PREPARAR DICHA FORMULACIoN GALÉNICA
AR059324A2 (es) Una forma solida de dosificacion oral
DE19375061I2 (de) Hexadecylphosphocolin enthaltende arzneimittel mit antitumorwirkung.
ES2038122T3 (es) Un procedimiento para la preparacion de una composicion veterinaria2.
MX9205922A (es) Composiciones de sales de antibiotico lipofilico oligosacarido.
ES2097297T3 (es) Isoquinolein-5-il-sulfonamidas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
ZA821137B (en) Antimycotic agent,in the form of sticks,with a high release of active compound
NO1998013I1 (no) Amfotericin B Lipid-kompleks
ES2027773T3 (es) Dispositivo auto-adhesivo para administracion de un principio activo por via percutanea.
FR2674754B1 (fr) Composition medicamenteuse micronisee.
ES2095861T3 (es) Composiciones con antibioticos estabilizadas para la alimentacion animal.
AR022250A1 (es) Envase farmaceutico de uso para el tratamiento y prevencion de infecciones por el virus de la hepatitis b, procedimiento para el tratamiento de pacientes o pacientes susceptibles en padecer infecciones por el virus de la hepatitis b.
GB2021409A (en) Pharmaceutical composition
SE8501532L (sv) Nya lekemedelskombinationer med synergistisk verkan och forfarande for deras framstellning
ES2092559T3 (es) Formulacion farmaceutica que contiene penciclovir.
DE3175733D1 (en) An orally administered drug form comprising a glycosidic antibiotic and an adjuvant
HUT61561A (en) Process for producing octadecyl-/2-(n-methylpiperidino)-ethyl/-phosphate and pharmaceutical compositions comprising same as active ingredient
GB1067390A (en) Improvements in or relating to antiviral compositions and treatments

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed